Recombinant Human RPL17 Protein，His

RPL17, a crucial ribosomal protein, is part of the 60S subunit of the eukaryotic ribosome and plays an essential role in protein synthesis. Research into RPL17 has garnered attention due to its involvement in various cellular processes and its implications in human health, particularly in cancer studies. Abnormal expression levels of RPL17 have been associated with tumorigenesis and the progression of several malignancies, indicating its potential as a biomarker for cancer diagnosis and prognosis. Moreover, RPL17 has been implicated in the regulation of the cell cycle and apoptosis, demonstrating its significance in maintaining cellular homeostasis. Given these critical functions, the study of recombinant RPL17 protein, including its structure and interactions, is essential to understand its role in ribosome assembly and function. This research may reveal novel insights into the molecular mechanisms underlying diseases and contribute to the development of therapeutic strategies, including targeted treatments in cancer and other disorders linked to ribosomal dysfunction. The recombinant production of RPL17 allows for detailed biochemical assays and structural analysis, facilitating the exploration of its functional properties and interactions with other ribosomal components. Furthermore, understanding the precise mechanisms by which RPL17 influences ribosome activity could lead to advancements in bioengineering and synthetic biology. Overall, the investigation of RPL17 as a recombinant protein holds significant promise for elucidating its biological roles and therapeutic potential, reinforcing the importance of ribosome biology in health and disease.